Market revenue in 2023 | USD 300.9 million |
Market revenue in 2030 | USD 402.9 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Cardiopulmonary perfusion system |
Fastest growing segment | Cardiopulmonary Perfusion System |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System |
Key market players worldwide | Getinge AB ADR, Medtronic PLC, LivaNova PLC, Terumo Corp, Nipro Corp, Fresenius Medical Care AG, Repligen Corp, Spectrum Brands Holdings Inc, Merck KGaA, Xvivo Perfusion AB |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to perfusion systems market will help companies and investors design strategic landscapes.
Cardiopulmonary perfusion system was the largest segment with a revenue share of 44.4% in 2023. Horizon Databook has segmented the Europe perfusion systems market based on cardiopulmonary perfusion system, cell perfusion system, ex-vivo organ perfusion system covering the revenue growth of each sub-segment from 2018 to 2030.
Europe is one of the most developed regions in the world. Increasing public & private investment in R&D are some of the significant factors contributing to the growth of this region. Rising demand for healthcare devices coupled with increasing prevalence of chronic diseases, such as respiratory failure and cardiopulmonary diseases, are major drivers anticipated to augment regional market growth.
Increasing demand for advanced technologies and rising health awareness are key factors expected to boost market growth. Growing healthcare expenditure in this region is expected to boost technological advancements in the healthcare industry.
Therefore, it can be one of the factors responsible for driving the perfusion system market. In addition, favorable reimbursement policies, increase in government investments in long-term healthcare plans, and growing healthcare research infrastructure are also expected to boost adoption of perfusion systems.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe perfusion systems market , including forecasts for subscribers. This continent databook contains high-level insights into Europe perfusion systems market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account